Edwards Lifesciences and PULSION Medical are Leading players in Hemodynamic Monitoring Systems Market
The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4%. The hemodynamic monitoring systems market is rapidly emerging with many regional as well as international companies. In 2017, Edwards Lifesciences Corporation (US), PULSION Medical Systems SE (Germany), and LiDCO Group plc (UK) dominated the hemodynamic monitoring systems market.
Edwards Lifesciences dominated the global hemodynamic monitoring systems market in 2017. The company’s Critical Care segment develops, manufactures, and markets hemodynamic products, such as the minimally invasive FloTrac systems and the noninvasive ClearSight system. Moreover, the firm also provides Swan-Ganz pulmonary artery catheters, Edwards oximetry central venous catheters, EV1000, and HemoSphere clinical monitoring platforms that enables clinicians to make proactive clinical decisions for their patients. To improve its R&D capabilities, Edwards partners with leading clinicians and researchers to deliver clinically advanced new products and expand the applications of its existing products. As part of its marketing and sales strategy, it focuses on participating in educational symposia, and sponsoring physician training to create awareness and increase the general understanding of its products and technologies in the medical field.
PULSION Medical is another major player operating in the hemodynamic monitoring systems market. The company maintains a large network of key opinion leaders, academics, leading clinicians, and experts in intensive care and anesthesia. This helps the company to gain valuable insights and access to new distribution channels and markets, providing new growth opportunities for the company to expand. The company focuses on improving its R&D capabilities to unlock additional synergies and growth opportunities. PULSION strives to receive regulatory approvals for its products so that it can enter diverse markets. Moreover, the company provides e-learning courses on advanced hemodynamic monitoring through its MLearning platform. It also conducts workshops and host symposia for doctors and nurses so as to provide a better understanding of the hemodynamic solutions offered by the company.
To know about the assumptions considered for the study download the pdf brochure
LiDCO is one of the major players in the hemodynamic monitoring systems market. The company mainly focuses on achieving inorganic growth by entering into agreements with other companies. The company further aims to increase its business and geographic presence beyond the US and UK. To achieve this, the company launched a new business model High Usage Programme (HUP) in July 2017, which aimed to attract larger established users of hemodynamic monitoring to adopt its products. As of January 2018, the company has installed 96 HUP-based monitors.
Some of the other players competing in this market are Cheetah Medical (Israel), Deltex Medical Group Plc. (UK), ICU Medical (US), Osypka Medical GmbH (Germany), Schwarzer Cardiotek GmbH (Germany), CareTaker Medical (US), CNSystems (Austria), NI Medical (Israel), and Uscom (Australia).
Related Reports:
Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
